Registry for Immunotherapy (BRIT)

About BRIT

The BSACI Registry for Immunotherapy (BRIT) is a web-based patient registry that records immunotherapy treatment of patients under the care of BSACI allergists, immunologists, GPs, dieticians and dermatologists practicing in the UK. BRIT is being rapidly adopted by centres across the United Kingdom.

Immunotherapy is a form of specialised treatment that can harness the immune system and reduce symptoms of a wide range of allergic and non-allergic diseases. BRIT focuses on immunotherapy by injection or by mouth for pollen and mite allergies, treatment of wasp and bee venom reactions, oral immunotherapy for peanut allergy (Palforzia, Stallergenes-Greer), and the use of omalizumab injections for chronic spontaneous urticaria (Xolair, Novartis). 

If you would like to know more about the registry, what we do or how to join, email BRIT at [email protected].

Putting patients at the centre of everything we do

There is a huge need to understand the effects immunotherapy has on patient outcomes. Although clinical research trials have shown benefit, it’s important that we can see this too when treating patients in the “real world” in clinic. Many registries are simply a place to put data for others to use but BRIT is not like that, there are lots of direct benefits for patients and clinicians:

• Patient data is accessible for direct clinical decision-making
• It’s a clinical tool that allows patients and their clinicians to see if their treatment is working
• Many treatments keep working after they have been stopped. BRIT participants can continue to provide long term follow up data to the registry once they have been discharged from active treatment
• The registry will help us monitor the effectiveness of immunotherapy as well as provide us with an evidence base in which to guide commissioning of services and guideline development
• The registry enhances patient safety by recording serious adverse events that take place during immunotherapy treatment
• Centres can download their data at the touch of a button to use for departmental audits and IQAS reports to accredit the quality of existing services
• BRIT has the potential to provide the data that we need to ensure national funding for specialist allergy services
• BRIT will help to map services and will be able to document how far the patient had to travel to receive their care, as well as residential IMD codes to investigate socio-economic disadvantage

Click here to log in to BRIT

Click here to register for BRIT

Click here for clarification from BSACI on the use of unlicensed medicines in the BRIT Registry